K. Elias

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Mattia D’Agostino, David A. Cairns, Juan José Lahuerta et al. · Journal of Clinical Oncology · 2022 · 371 citations · Full text

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes

K. Martin Kortüm, K. Elias, Nur Hafzan Md Hanafiah et al. · Blood · 2016 · 243 citations · Full text

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

Hartmut Goldschmidt, K. Elias, Uta Bertsch et al. · The Lancet Haematology · 2022 · 142 citations

Transplantation-eligible Patients, Hematological Malignancy, Part 1 +9

Genomic Classification and Individualized Prognosis in Multiple Myeloma

Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu et al. · Journal of Clinical Oncology · 2024 · 95 citations · Full text

Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalities.

Christos Sachpekidis, Jennifer Mosebach, Martin T. Freitag et al. · PubMed · 2015 · 66 citations

Oncologic Imaging, Pet-mri, Pathology +18